Antonio De Leo

No ORCID on file · 18 papers in corpus · active 2018-2026

Study types

  • article 10
  • other 2
  • review 1

Condition tags

  • endometriosis 13
article 2026
·doi:10.1016/j.labinv.2025.105329
article 2025
·doi:10.1016/j.labinv.2024.103295
article 2025
article 2025
article 2025
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.101990

OBJECTIVE: Mesonephric-like adenocarcinoma is a rare, aggressive ovarian cancer subtype, newly classified by the World Health Organization in 2020. This study examines the clinical, ultrasound, pathological features, and survival outcomes o…

other 2025
Translational oncology ·doi:10.1016/j.tranon.2025.102367

BACKGROUND: Endometriosis (EMS) is a chronic, gynecological condition affecting 6-10 % of reproductive-age women. While these lesions are benign, ovarian EMS presents cancer-like features, and can progress to endometriosis-correlated ovaria…

other 2025
Scientific reports ·doi:10.1038/s41598-025-26466-3

Endometriosis (EMS) is a chronic gynecological condition affecting 6-10% of reproductive-age women. These lesions, albeit of benign nature, present cancer-like features, and may progress to epithelial ovarian cancer (EOC) through a multiste…

article 2025
·doi:10.1016/j.ijgc.2024.100413
article 2025
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.101634

OBJECTIVE: This study aimed to describe 2 types of endometriosis-associated ovarian cancer: those with transitional elements (atypical endometriosis and borderline tumors) termed endometriosis-correlated or incidental benign endometriosis v…

article 2024
·doi:10.1136/ijgc-2024-esgo.794
article 2024
·doi:10.1136/ijgc-2024-esgo.62
article 2024
·doi:10.1136/ijgc-2024-esgo.623
2023
International journal of molecular sciences ·doi:10.3390/ijms24108940

Despite significant therapeutic advances, metastatic CRPC (mCRPC) remains a lethal disease. Mutations in homologous recombination repair (HRR) genes are frequent in mCRPC, and tumors harboring these mutations are known to be sensitive to PA…

2021
Cancers ·doi:10.3390/cancers13040836

According to our systematic literature review (PRISMA guidelines), only 37 vulvar squamous cell carcinomas (VSCCs) were diagnosed during pregnancy (age range: 17-41 years). The tumor size range was 0.3-15 cm. The treatment was performed aft…

2021
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics11020199

The term "ovarian carcinoma" encompasses at least five different malignant neoplasms: high-grade serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, mucinous carcinoma, and clear cell carcinoma. These five histotypes demon…

review 2021
Diagnostics ·doi:10.3390/diagnostics11040697

Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate entities with distinct risk factors, precursor lesions, pathogenesis, patterns of spread, molecular profiles, clinical course, response to chemotherapy, …

2020
International journal of molecular sciences ·doi:10.3390/ijms21197188

Since 2016, our hospital has applied tumor testing with immunohistochemistry (IHC) in endometrial cancer in order to detect mutations of mismatch repair genes (MMR). All cases with MMR deficiency proteins expression are sent for genetic tes…

2018
Clinical Medicine Insights. Oncology ·doi:10.1177/1179554918782477

Adenosarcomas are the rarest form of uterine sarcomas, and clinical experience with their management is still limited. Here, we reported 7 patients with uterine adenosarcoma referred to our institution, focusing on main pathologic features,…